Heart failure is a complex syndrome; therapy should be aimed at the in
dependent goals of prolonging life and of improving symptoms and quali
ty of life. Some therapies are effective in achieving one goal but not
the other. Shortterm symptomatic relief may relate to alleviation of
haemodynamic abnormalities and of congestion, whereas slowing progress
ion of the disease and reducing mortality involve neurohormonal mechan
isms, left ventricular remodelling and arrhythmia generation. Current
therapy is moderately effective on these end-points, but newer approac
hes to management are necesssary to produce more profound improvements
in morbidity and mortality.